The presacral retroperitoneal approach for axial lumbar interbody fusion (presacral ALIF) is not widely reported, particularly with regard to the mid-term outcome. This prospective study describes the clinical outcomes, complications and rates of fusion at a follow-up of two years for 26 patients who underwent this minimally invasive technique along with further stabilisation using pedicle screws. The fusion was single-level at the L5-S1 spinal segment in 17 patients and two-level at L4-5 and L5-S1 in the other nine. The visual analogue scale for pain and Oswestry Disability Index scores were recorded pre-operatively and during the 24-month study period. The evaluation of fusion was by thin-cut CT scans at six and 12 months, and flexion-extension plain radiographs at six, 12 and 24 months. Significant reductions in pain and disability occurred as early as three weeks postoperatively and were maintained. Fusion was achieved in 22 of 24 patients (92%) at 12 months and in 23 patients (96%) at 24 months. One patient (4%) with a pseudarthrosis underwent successful revision by augmentation of the posterolateral fusion mass through a standard open midline approach.
The presacral retroperitoneal approach for axial lumbar interbody fusion (presacral ALIF) is not widely reported, particularly with regard to the mid-term outcome. This prospective study describes the clinical outcomes, complications and rates of fusion at a follow-up of two years for 26 patients who underwent this minimally invasive technique along with further stabilisation using pedicle screws. The fusion was single-level at the L5-S1 spinal segment in 17 patients and two-level at L4-5 and L5-S1 in the other nine. The visual analogue scale for pain and Oswestry Disability Index scores were recorded pre-operatively and during the 24-month study period. The evaluation of fusion was by thin-cut CT scans at six and 12 months, and flexion-extension plain radiographs at six, 12 and 24 months. Significant reductions in pain and disability occurred as early as three weeks postoperatively and were maintained. The standard open techniques of lumbar interbody fusion, which include the anterior (ALIF), posterior (PLIF) and transforaminal (TLIF) approaches, have recently been modified to become minimally invasive and renamed mini-open A-, P-and TLIF. [1] [2] [3] [4] [5] With further refinement, TLIF may be performed through a 20 mm to 30 mm tubular retractor with skin incisions as small as 2 cm. [5] [6] [7] [8] The clinical outcomes from these approaches have been shown to be similar to or better than those reported for conventional open approaches. 6, [8] [9] [10] However, interbody fusion using standard A-, P-or TLIF can only be accomplished by cutting into or traumatising the supporting segmental structures, such as the anterior or posterior longitudinal ligaments, annulus, facets, lamina and muscle. Also, these approaches require partial destabilisation of the segment before it can be stabilised. 4, 9, [11] [12] [13] Some complications are related to each particular approach. Visceral, vascular and presacral plexus injuries may be seen with ALIF, and direct injury to a nerve root and dural laceration are complications that may accompany PLIF and TLIF. 11, 12, 14, 15 An interbody fusion via a presacral retroperitoneal approach to the L5-S1 interspace and disc offers an alternative that spares the annulus and supporting tissues. [16] [17] [18] [19] Although the presacral and conventional ALIF approaches are retroperitoneal, they differ in how the retroperitoneal space is entered. The presacral space is contiguous with the fatty plane used by the conventional retroperitoneal ALIF approach. After clearance by the Food and Drug Administration (FDA) in 2004, this presacral approach was adopted for interbody fusion. 20 Unlike other traditional interbody techniques, the disc is not directly exposed; rather the entire procedure is undertaken fluoroscopically. The indications for presacral ALIF are disorders that require fusion at L5-S1, such as degenerative disc disease and grades 1 or 2 21 spondylolisthesis. This prospective study was designed to evaluate the safety and effectiveness of presacral ALIF over a two-year period.
THE JOURNAL OF BONE AND JOINT SURGERY
Patients and Methods
In this prospective study 26 patients underwent presacral ALIF at L5-S1 with an AxiaLIF implant (TranS1 Inc., Wilmington, North Carolina) (Fig. 1) Of the 26 patients, 17 underwent fusion at L5-S1 alone and nine had an additional TLIF at L4-5 at the same operation. A small skin incision (≤ 2 cm) was placed posteriorly near the sacrococcygeal junction. Subcutaneous tissues were divided and access to the presacral space gained in a retroperitoneal manner by puncturing a single fascial layer (the anorectal fascia/ligament) located just underneath the sacrococcygeal ligament. Following discectomy and interspace bone grafting, a threaded titanium dowel was placed axially across the interspace to maintain or restore its height and provide anterior column support. The dowel, or axial rod, is manufactured in a variety of differential thread counts for either end. When inserted, the threads can distract a disc space using a reverse Herbert Screw effect. 22 Distraction during the healing phase is maintained by the angulation of the rod across the space and the strength and integrity of the endplate.
Bone morphogenetic protein (BMP; Infuse; Medtronic, Minneapolis, Minnesota) and Vitoss (Orthovita, Malvern, Pennsylvania) was placed in the interbody space of 23 patients and bone marrow aspirate on a collagen sponge (Healos; DePuy Spine, Raynham, Massachusetts) in the other three. In each case, 2 ml to 5 ml of autograft taken from the channel created in the sacrum was implanted in the disc space. All patients also underwent simultaneous pedicle screw fixation by a minimally invasive paraspinous approach to supplement the AxiaLIF procedure.
Pre-operative MRI or CT scans and anteroposterior (AP) and lateral flexion-extension radiographs were undertaken. Post-operative imaging included CT and lateral flexionextension radiographs to assess fusion and associated features including vertebral fracture, subsidence and loosening of the implants. The extent of fusion was determined according to FDA guidance. 19 The CT scans were done at the six-and 12-month follow-up and lateral flexion-extension radiographs at six, 12 and 24 months. The imaging studies were assessed by an independent radiologist (MM) using the eFILM version 2.01 software (Merge Healthcare, Milwaukee, Wisconsin). Radiolucency, subsidence or loosening of the implant, damage to the vertebrae or implant, and bone formation were recorded. Within the L5-S1 disc space, bone formation or movement at six, 12 and 24 months was assessed using our classification of fusion status (Table I) , which is based on thin-section, high-resolution multiplanar CT scans. Further evaluation was conducted by a panel of reviewers, comprising the independent radiologist (MM), the principal investigator (WDT) and an orthopaedic surgeon (CS) who was a TranS1 medical advisor.
Clinical assessments were completed pre-and postoperatively, at discharge, and at three weeks and three, six, 12, and 24 months. Clinical outcomes were measured at each visit using the Oswestry Disability Index (ODI) 23 and a visual analogue scale (VAS; 0 to 100) for low back pain. Statistical analysis. Demographics and clinical results are presented as descriptive statistics or frequency and Diagrams showing the surgical anatomy of the sacrum and coccyx. In order to assess the feasibility of the presacral retroperitoneal approach for axial lumbar interbody fusion, a line is drawn on the midsagittal MRI scan from the probe's entry point below the sacrococcygeal joint to the midpoint of the S1 endplate (red line). The implant is placed within the central shaded area (with permission from Mayfield Clinic).
percentage distributions, as appropriate. Baseline values were compared with values at two years using a two-sided Student's t-test. A p-value < 0.05 was considered to be statistically significant.
Results
The mean operative times were 191 minutes (137 to 235) for single-level fusions and 256 minutes (216 to 309) for multilevel fusions, including the time for the ancillary posterior fixation and all procedures in a multilevel operation. The mean blood loss was 137 ml (50 to 275) in singlelevel cases and 363 ml (50 to 600) in two-level cases. Blood loss was largely attributed to the posterior approach, with its dissection of muscle, facetectomy and decompression, all of which involve increased loss in two-level fusions. Blood loss from the presacral approach was due to back bleeding from the freshly drilled sacral channel. The mean time to discharge was slightly shorter for single-level patients than for multilevel patients (2.5 vs 2.7 days). Two patients missed their six-month follow-up but returned at 12 months, and two were lost to follow-up during this period. At the 24-month follow-up 15 patients had lateral-flexion extension radiographs, nine did not have complete imaging studies within protocol guidelines, and 17 had complete VAS and ODI assessments. The mean VAS decreased from 67 (20 to 100) pre-operatively to 37 (10 to 80) at 12 months and 37 (0 to 86) at 24 months (p = 0.0034 and p = 0.0070, respectively). The mean reduction in the VAS at 12 months was 20 (0 to 40) for men and 33 (0 to 40) for women (p = 0.7225 and p = 0.1908, respectively) (Fig. 2) . At 24 months, the mean improvement was similar for both men (24 (0 to 50)) and women (26 (0 to 50)). The mean VAS at three months post-operatively decreased by 35 (0 to 40) after a single-level fusion and by 10 (0 to 40) after a multilevel fusion. The mean ODI score improved from 49% (30% to 86%) pre-operatively to 27% (4% to 72%) at 24 months (p = 0.0020) (Fig. 3) . There was no statistically significant difference between men and women in respect to the 12-and 24-month ODI scores (p = 0.8615 and p = 0.7225, respectively, one-way ANOVA: Neuman-Keuls comparison). The mean scores improved by 23% for women and 20% for men at 24 months (Fig. 4) . By level of involvement, the mean three-week ODI scores decreased by 2% in patients after a single-level fusion and increased by 12% in patients who had multilevel fusion.
Thus, at 24 months for single and multilevel fusions, the improvements were significant for back pain, as scores decreased by a mean of 30 in VAS and 22% in ODI scores.
On CT examination at six months, 17 (74%) of 23 patients had fusion, three with advanced fusion grade I and 14 with grade II (Table I , Figs 5a and 5b). Another four had developing bone emanating from the endplates (grade III, Fig. 5c ). Two had no evidence of bone remodelling (grade V, Fig. 5d ). At the 12-month follow-up, 22 of 24 patients had fused bone (92%), including 18 with advanced fusion grade I and four with grade II. Of the two patients who were not fused, one was developing bone that had not yet bridged (grade III, with a stable implant and a clinically significant reduction in pain and disability). The other, who had a pseudarthrosis on CT and unrelieved pre-operative pain, underwent a posterior revision which included a wide exposure and decortication of the L5 transverse processes, facets and alae of the sacrum with the addition of BMP and allograft, and with larger pedicle screws.
At 24 months, 14 of 15 patients (93%) with appropriate radiographs were fused. Of the nine who did not have complete imaging studies three had fused on CT scans at one year and six had fused on CT between 18 and 24 months (outside the protocol study period). Thus, at 24 months, 23 patients (96%) had fused.
No patient had any damage to the vertebral bodies at L5 or S1, such as fracture, backout, loosening or migration of the axial rod, damage to the implant or subsidence. At the six-month follow-up two patients had small areas of bone resorption and at 12 months, three had radiolucencies around the rod, one of whom had failure after a multilevel fusion and underwent removal of the pedicle screws. The second had some radiolucency and focal resorption at six months, but bone was developing. He progressed to fusion at 12 months, but continued to have some radiolucency and resorption. The third patient was a 20-year-old woman of normal weight (BMI 23). Imaging studies were not obtained at six months, but showed bridging bone at 12 months despite some radiolucency around the tip of the rod.
There were no severe complications associated with the presacral approach. Of the 34 lesser complications, ten were after single-level and 24 followed multilevel surgery. They included pedicle screw removal for pain (seven cases), painful foraminal stenosis (two) and single cases of a painful incision, nerve impingement from a pedicle screw and an unrelated rectal carcinoma requiring chemotherapy.
Discussion
Our patients who underwent presacral ALIF had a significant reduction in pain and disability, 24 with rates comparable to those after conventional approaches for interbody fusion. 1, 8 At six months, the reductions in VAS and ODI were clearly evident, and they remained so at 24 months. Our data at 24 months are limited because protocolspecified follow-ups, namely, the flexion-extension plain radiographs, were not done for all patients, a number of whom underwent CT scanning instead. CT scans at one year post-operatively of different grades of fusion, showing a) grade I, continuous bridging bone extending from the L5 to the S1 endplate and occupying > 50% of the available space for fusion; b) grade II, bridging bone extending from the L5 to the S1 endplate and occupying < 50% of the available space for fusion; c) grade III, developing bone and bone connected to either L5 or the S1 endplate without bridging; and d) grade V, a pseudarthrosis (with permission from the Mayfield Clinic). The rate of fusion was comparable with that in patients undergoing conventional interbody fusion, superior to allograft bone dowels, and equivalent to fusions enhanced with BMP. 1, 3, [25] [26] [27] [28] [29] The blood loss was less and hospital stays shorter for our patients than for those reported after open approaches. Hospital stays after PLIF were twice as long as after presacral ALIF. 1, 8, 9, 12, 15, 25, 28 Obese patients usually have a larger presacral fat pad which displaces the rectum and renders the approach easier. Also, the distance from the incision to the L5-S1 disc space is fixed, regardless of weight. Therefore, unlike other approaches, the difficulties and risks of presacral ALIF are not greater with increasing obesity.
Other studies have demonstrated similar ODI outcomes after one year, ranging from 45% to 50% pre-operatively to 18% to 22% at 12 months after conventional ALIF. 8, 30 However, compared with ALIF, PLIF, or TLIF, the potential surgical benefits of the minimally invasive approach include minimising disruption to the surrounding tissue, allowing the structural bony margins to remain intact, lessening the risk of vascular damage and maintaining the anterior longitudinal ligament and facets to retain spinal stability, thereby reducing the risk of displacement of the implant. These benefits are effective from the outset.
In biomechanical studies, presacral ALIF has superior stability with respect to stiffness and range of movement compared to conventional ALIF and TLIF techniques. 19, 31 In particular, removal of the anterior and posterior longitudinal ligaments and facet joints can significantly destabilise the spine and increase movement across the spinal segment. Torsional stability in biomechanical testing for the AxiaLIF interbody device was similar to that of others, all of which play only a secondary role in reducing torsion. 19 Therefore, supplementary fixation with pedicle screws is often advised with A-, T-or PLIF in which stability is worsened by distraction of ligaments and facets. Pedicle screw and/or transfacet fixation to increase torsional stability is particularly useful in the presacral ALIF approach, as it provides posterior column stability across the fusion site, and added resistance to torsion. 32, 33 The presacral ALIF approach may be associated with significant complications. 17, 20 Perforation of the rectal wall can occur if the presacral space is developed inadequately. Previous surgery in this space with resulting scarring is a contraindication to the approach. Deviation of a probe from the midline can injure the sacral nerve roots. Failure to recognise a vascular anomaly such as an aberrant iliac vein during pre-operative evaluation, or advancement of a probe above the L5-S1 disc space, can injure the iliac vessels. These complications are avoidable.
Back-out or migration of the axial rod should not occur with proper placement in patients with adequate bone density. An improper trajectory or failure to obtain highquality orthogonal fluoroscopic images increases the risks of placing it outside the vertebral body or in the spinal canal, and incomplete drilling of the sacral L5 channel or placement of the implant too far anteriorly could cause a sacral fracture. However, none of our patients developed any of these complications.
Despite observations that radiolucency and bone resorption were present, albeit diminished, at the 12-month follow-up, two patients with such findings achieved bridging bone or solid fusions. Radiolucency around any implant is a mechanical phenomenon resulting in bone deformation. The causes of bone resorption and radiolucency are related to the fixation at the site of fusion, the load-sharing environment and micromovement at the implant-bone interface, possibly due to osteolysis caused by BMP. [34] [35] [36] [37] Whereas excessive micromovement can lead to radiolucencies and nonunion, minimal micromovement can indicate the necessary stress which ultimately stimulates bone growth. Although these two terms differ by definition, they both relate to the assessment of bone integrity. However, the progression to solid fusion in two of these patients was indicative of a stable fusion site, despite the radiolucencies.
Further opinion
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